ICAD · Icad Inc - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.87M | - | $4.07M | $5.03M | $4.95M | - | - | $5.87M | $5.78M | - |
| Cost of Revenue | $685.0K | - | $583.0K | $812.0K | $841.0K | - | $552.0K | $1.52M | $1.65M | - |
| Gross Profit | $4.19M | - | $3.63M | $4.22M | $4.11M | - | $3.52M | $4.35M | $4.13M | - |
| R&D | $1.48M | - | $1.93M | $1.76M | $1.51M | - | $1.15M | $1.26M | $2.28M | - |
| SG&A | $2.25M | - | $1.81M | $2.07M | $1.90M | - | $2.04M | $2.83M | $2.86M | - |
| Total Operating Expenses | $5.32M | - | $5.65M | $6.17M | $5.55M | - | $4.74M | $6.27M | $8.05M | - |
| D&A | $56.0K | - | $56.0K | $64.0K | $63.0K | - | $56.0K | $65.0K | $55.0K | - |
| Operating Income | ($1.13M) | - | ($2.02M) | ($1.95M) | ($1.44M) | - | ($1.22M) | ($1.92M) | ($3.92M) | - |
| Interest Expense | - | - | $0 | $2.0K | $0 | - | $0 | $0 | $0 | - |
| Income Tax | $0 | - | $6.0K | $8.0K | $4.0K | - | $4.0K | $4.0K | $1.0K | - |
| Net Income | ($833.0K) | - | ($1.80M) | ($1.74M) | ($1.22M) | - | ($1.37M) | ($1.75M) | ($3.78M) | - |
| EPS - Basic | ($0.03) | - | ($0.07) | ($0.07) | ($0.05) | - | ($0.05) | ($0.07) | ($0.15) | - |
| EPS - Diluted | - | - | - | - | - | - | - | - | - | - |
Balance Sheet
| Line item | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $20.03M | $17.21M | $18.79M | $20.35M | $20.28M | $21.67M | $19.05M | $19.04M | $19.66M | $21.31M |
| Accounts Receivable | $6.63M | $7.21M | $5.42M | $5.38M | $6.51M | $6.39M | $4.87M | $5.75M | $7.38M | $8.90M |
| Inventory | $694.0K | $756.0K | $689.0K | $702.0K | $750.0K | $917.0K | $992.0K | $4.25M | $4.87M | $5.39M |
| Accounts Payable | $1.14M | $1.11M | $422.0K | $501.0K | $635.0K | $712.0K | $1.10M | $857.0K | $1.89M | $1.97M |
| Current Assets | $28.12M | $26.43M | $26.11M | $27.82M | $29.04M | $29.68M | $32.34M | $31.34M | $34.20M | $38.24M |
| Total Assets | $39.47M | $37.54M | $37.11M | $38.94M | $40.40M | $41.42M | $45.83M | $44.83M | $47.52M | $51.70M |
| Current Liabilities | $7.69M | $7.56M | $6.50M | $6.56M | $6.16M | $6.75M | $11.41M | $11.89M | $12.88M | $13.45M |
| Long-term Debt | - | - | - | - | - | - | - | - | - | - |
| Total Liabilities | $8.68M | $8.86M | $7.73M | $7.98M | $7.93M | $8.00M | $14.79M | $14.66M | $15.81M | $16.80M |
| Stockholders' Equity | $30.79M | $28.68M | $29.37M | $30.96M | $32.46M | $33.42M | $31.04M | $30.17M | $31.71M | $34.90M |
| Retained Earnings | ($278.13M) | ($277.30M) | ($276.44M) | ($274.64M) | ($272.90M) | ($271.68M) | ($273.74M) | ($272.36M) | ($270.61M) | ($266.84M) |
Cash Flow
| Line item | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $60.0K | - | - | - | ($1.18M) | - | - | - | ($1.53M) | - |
| Investing Cash Flow | $431.0K | - | - | - | ($206.0K) | - | - | - | ($122.0K) | - |
| Financing Cash Flow | $0 | - | - | - | - | - | - | - | $0 | - |
| CapEx | $2.0K | - | - | - | $106.0K | - | - | - | $122.0K | - |
| Free Cash Flow | $58.0K | - | - | - | ($1.29M) | - | - | - | ($1.65M) | - |
Ratios
| Metric | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | 85.9% | - | 89.2% | 83.9% | 83.0% | - | - | 74.2% | 71.5% | - |
| Operating margin | -23.2% | - | -49.5% | -38.7% | -29.1% | - | - | -32.8% | -67.9% | - |
| EBITDA margin | -22.0% | - | -48.1% | -37.5% | -27.8% | - | - | -31.7% | -67.0% | - |
| Net margin | -17.1% | - | -44.2% | -34.6% | -24.7% | - | - | -29.8% | -65.4% | - |
| Free cash flow margin | 1.2% | - | - | - | -26.0% | - | - | - | -28.6% | - |
| FCF / Net income | -0.07 | - | - | - | 1.05 | - | - | - | 0.44 | - |
| R&D / Revenue | 30.3% | - | 47.3% | 35.1% | 30.4% | - | - | 21.5% | 39.5% | - |
| SG&A / Revenue | 46.2% | - | 44.3% | 41.2% | 38.4% | - | - | 48.3% | 49.5% | - |
| Effective tax rate | - | - | - | - | - | - | - | - | - | - |
| Return on assets | -2.1% | - | -4.9% | -4.5% | -3.0% | - | -3.0% | -3.9% | -8.0% | - |
| Return on equity | -2.7% | - | -6.1% | -5.6% | -3.8% | - | -4.4% | -5.8% | -11.9% | - |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 3.66 | 3.50 | 4.02 | 4.24 | 4.71 | 4.40 | 2.83 | 2.64 | 2.66 | 2.84 |
| Quick ratio | 3.57 | 3.40 | 3.91 | 4.13 | 4.59 | 4.26 | 2.75 | 2.28 | 2.28 | 2.44 |
| Cash ratio | 2.60 | 2.28 | 2.89 | 3.10 | 3.29 | 3.21 | 1.67 | 1.60 | 1.53 | 1.58 |
| Leverage | ||||||||||
| Debt / Equity | - | - | - | - | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | - | - | - | -974.0x | - | - | - | - | - | - |
| Equity multiplier | 1.28 | 1.31 | 1.26 | 1.26 | 1.24 | 1.24 | 1.48 | 1.49 | 1.50 | 1.48 |
| Liabilities / Assets | 0.22 | 0.24 | 0.21 | 0.20 | 0.20 | 0.19 | 0.32 | 0.33 | 0.33 | 0.32 |
| Efficiency | ||||||||||
| Asset turnover | 0.12 | - | 0.11 | 0.13 | 0.12 | - | - | 0.13 | 0.12 | - |
| Inventory turnover | 0.99 | - | 0.85 | 1.16 | 1.12 | - | 0.56 | 0.36 | 0.34 | - |
| Days sales outstanding | 496d | - | 485d | 391d | 480d | - | - | 358d | 466d | - |
| Days inventory outstanding | 370d | - | 431d | 316d | 326d | - | 656d | 1023d | 1078d | - |
| Days payable outstanding | 605d | - | 264d | 225d | 276d | - | 726d | 206d | 418d | - |
| Cash conversion cycle | 261d | - | 652d | 481d | 530d | - | - | 1174d | 1126d | - |
| Valuation | ||||||||||
| P / E | - | - | - | - | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | -1.6% | - | - | -14.3% | -14.3% | - | - | -22.6% | -23.2% | - |
| Revenue CAGR (3y) | -13.5% | - | -24.2% | -13.7% | -16.9% | - | - | 1.8% | -4.1% | - |
| Revenue CAGR (5y) | -5.7% | - | -12.3% | -7.3% | -6.1% | - | - | -1.8% | -2.8% | - |
| Gross profit growth (YoY) | 1.8% | - | 3.2% | -3.0% | -0.4% | - | -19.5% | -20.8% | -22.3% | - |
| Operating income growth (YoY) | 21.7% | - | -65.3% | -1.3% | 63.3% | - | 69.2% | 38.2% | -11.4% | - |
| Net income growth (YoY) | 31.8% | - | -31.1% | 0.6% | 67.7% | - | 64.8% | 43.9% | -6.6% | - |
| EPS growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | - | - | 22.1% | - | - | - | 64.1% | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | -5.2% | -14.2% | -5.4% | 2.6% | 2.4% | -4.3% | -17.6% | -26.4% | -27.5% | -25.0% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2024-12-31.
Product / service
$19.61M totalProducts And Perpetual Licenses$7.33M · 37.4%
Services And Support$7.08M · 36.1%
Subscription Term Licenses$4.97M · 25.4%
Cloud Subscriptions$234.0K · 1.2%
Geographic
$2.70M totalNon Us$2.70M · 100.0%
Peer comparison
Same SIC group: Surgical & Medical Instruments & Apparatus
Comparing ICAD INC against the 5 most active filers in the same SIC group.